Chennai: Indian drug major Sun Pharmacuetical Industries Ltd on Tuesday said it will launch the generic version of Glumetza, Metformin Hydrochloride tablets – a diabetes drug – soon in the US.
Also Read: SPARC and Sun Pharma ink licensing pact for epilepsy drug
The company said in a statement, that one of its subsidiaries got the final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for generic version of Glumetza, Metformin Hydrochloride extended release tablets 500 mg and 1,000 mg.
“These Metformin Hydrochloride extended release tablets are therapeutic equivalents of Santarus Inc’s Glumetza tablets,” the statement said.
Also Read: Sun Pharma in $50 million deal with Spanish firm
The tablets may have an annual sales of around $1.2 billion in the US, the company added.
